Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes
Stem Cell Reports, ISSN: 2213-6711, Vol: 8, Issue: 4, Page: 803-812
2017
- 111Citations
- 496Captures
- 10Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations111
- Citation Indexes103
- 103
- CrossRef75
- Patent Family Citations8
- Patent Families8
- Captures496
- Readers496
- 496
- Mentions10
- News Mentions6
- News6
- Blog Mentions4
- Blog4
Most Recent Blog
Synthetic Bio Company Manufactures Research Cells
Synthetic Bio Company Manufactures Research Cells By Alan, on June 15th, 2023 Healthy neuron illustration (NIH, Flickr. https://flic.kr/p/CW1m6P) 15 June 2023. A synthetic biology company
Most Recent News
Industry Insight Transformative Models for Research and Drug Discovery Technology Networks spoke to Dr. Mark Kotter, CEO and founder of bit.bio to learn about opti-ox™ and the development, benefits and applications of ioSkeletal Myocytes.
The dawn of stem cell technologies has opened new possibilities in drug discovery and development by providing new research tools for drug screening, target identification
Article Description
The isolation or in vitro derivation of many human cell types remains challenging and inefficient. Direct conversion of human pluripotent stem cells (hPSCs) by forced expression of transcription factors provides a potential alternative. However, deficient inducible gene expression in hPSCs has compromised efficiencies of forward programming approaches. We have systematically optimized inducible gene expression in hPSCs using a dual genomic safe harbor gene-targeting strategy. This approach provides a powerful platform for the generation of human cell types by forward programming. We report robust and deterministic reprogramming of hPSCs into neurons and functional skeletal myocytes. Finally, we present a forward programming strategy for rapid and highly efficient generation of human oligodendrocytes.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2213671117300838; http://dx.doi.org/10.1016/j.stemcr.2017.02.016; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85016049212&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28344001; https://linkinghub.elsevier.com/retrieve/pii/S2213671117300838; http://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2817%2930083-8#.WNgk7HKJTvA.twitter; http://www.cell.com/article/S2213671117300838/abstract; http://www.cell.com/article/S2213671117300838/fulltext; http://www.cell.com/article/S2213671117300838/pdf; https://www.cell.com/stem-cell-reports/abstract/S2213-6711(17)30083-8; http://linkinghub.elsevier.com/retrieve/pii/S2213671117300838
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know